These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3071441)

  • 1. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin.
    Dorchy H; Duchateau J; D'Hooge D
    Diabete Metab; 1988; 14(4):415-21. PubMed ID: 3066649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of insulin antibodies, metabolic control and B-cell function in newly diagnosed insulin dependent diabetic children treated with monocomponent human insulin or monocomponent porcine insulin.
    Marshall MO; Heding LG; Villumsen J; Akerblom HK; Baevre H; Dahlquist G; Kjaergaard JJ; Knip M; Lindgren F; Ludvigsson J
    Diabetes Res; 1988 Dec; 9(4):169-75. PubMed ID: 3073903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.
    Ludvigsson J
    Diabetologia; 1984 Feb; 26(2):138-41. PubMed ID: 6370760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of human insulin in cases of insulin allergy].
    Gerö L; Kerényi Z; Bányai Z; Tamás G
    Orv Hetil; 1989 May; 130(22):1159-62. PubMed ID: 2668841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultratard HM, a new human insulin. Advantages as compared to current preparations?].
    Saner B; Fankhauser S
    Schweiz Med Wochenschr; 1986 Jan; 116(4):116-9. PubMed ID: 3513303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial with monocomponent lente insulins. Preliminary report.
    Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
    Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of monocomponent human and porcine insulin in newly diagnosed type 1 (insulin-dependent) diabetic children.
    Heding LG; Marshall MO; Persson B; Dahlquist G; Thalme B; Lindgren F; Akerblom HK; Rilva A; Knip M; Ludvigsson J
    Diabetologia; 1984 Jul; 27 Suppl():96-8. PubMed ID: 6383927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of twice daily regimens of Actrapid and Monotard insulins.
    Akintewe TA
    East Afr Med J; 1985 Mar; 62(3):196-9. PubMed ID: 3893969
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
    [No Abstract]   [Full Text] [Related]  

  • 17. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B; Gamba S; Regis G; Turco GL
    Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monocomponent insulins (author's transl)].
    Rodriguez-Miñón JL
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1215-20. PubMed ID: 409943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study.
    Bruni B; Barolo P; Blatto A; Carlini M; Ansaldi SG; Grassi G
    Diabetes Care; 1988 Jan; 11(1):59-62. PubMed ID: 3276478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.